Abstract:

High intensity focused ultrasound (HIFU) technology is a non-invasive thermal tissue ablation method that can achieve image-guided therapy and treatment control through magnetic resonance guided high intensity focused ultrasound (MRgHIFU) or ultrasound guided high intensity focused ultrasound (USgHIFU). HIFU offers the advantages of being non-invasive, non-ionizing, and associated with fewer post-treatment complications. As a non-surgical treatment modality, HIFU technology has been increasingly applied in the treatment of obstetric and gynecological diseases over the past decade. HIFU achieves tissue ablation through precise focusing of ultrasound energy and has demonstrated efficacy in treating conditions such as uterine fibroids, cervical lesions, adenomyosis, non-neoplastic epithelial disorders of the vulva, caesarean scar pregnancy, abdominal wall endometriosis, uterine arteriovenous fistula, twin reversed arterial perfusion sequence, among others. Its benefits include reduced complications, suitability for patients with surgical contraindications, and shorter recovery times, which is particularly significant for women who have not yet had children. Although HIFU shows a promising outlook in the treatment of obstetric and gynecological diseases, further research is needed to assess its long-term effectiveness and safety. In the future, HIFU is expected to become a new treatment option for gynecological diseases, benefiting more patients.

Key words: Extracorporeal shock wave therapy, Leiomyoma, Adenomyosis, Cervical intraepithelial neoplasia, Papillomaviridae, Endometriosis, Non-neoplastic epithelial disorders of the vulva, Caesarean scar pregnancy, Uterine arteriovenous fistula, Twin reversed arterial perfusion sequence